Examination of Cavinton effect in elderly diabetic patients.
The effect of Cavinton tablet has been examined in elderly diabetic patients. According to the observations the intellectual performance of the treated patients improved significantly, and their neurological symptoms were moderated as well. The drug did not influence carbohydrate or lipid metabolisms nor did it affect the systemic blood pressure. The results obtained prove that the drug may successfully be used for the treatment of nervous symptoms of elderly diabetic patients. The assure an effective therapy the drug administration has to be started as early as possible--before the development of nervous symptoms. The dosage of the product has to be adjusted individually. Obviously, the currently accepted other drug therapies of manifesting nervous symptoms have to be used as well and the other diseases accompanying advanced age need also be treated.
Boda
J
J
Karsay
K
K
Czakó
L
L
Fügi
S
S
Kovács
A
A
Koncz
I
I
Maczkó
P A
PA
D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D002545:Brain Ischemia / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D014665:Vasodilator Agents / Q000008:administration & dosage*; D014748:Vinca Alkaloids / Q000008:administration & dosage*
D001786:Blood Glucose; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine